A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity

Congcong Liu, Keshuang Li, Meina Fu, Yingying Zhang, Cornelia Sindermann, Christian Montag, Xiaoxiao Zheng, Hongxing Zhang, Yao Shuxia, Zheng Wang, Bo Zhou, Keith M. Kendrick, Benjamin BeckermedRxiv 2023 · DOI

Introduction

Serotonin (5-HT) is a cornerstone of modern psychiatry, central to our understanding of emotion regulation and the treatment of mood disorders. However, experimental attempts to link serotonin levels directly to behavior often yield inconsistent results. One common method, Acute Tryptophan Depletion (ATD), which temporarily lowers brain serotonin levels, produces anxiogenic effects in some individuals but not in others. This study investigates whether genetic variations in the Tryptophan hydroxylase 2 (TPH2) gene—the rate-limiting enzyme for serotonin synthesis in the brain—explain this variability. Specifically, researchers examined the rs4570625 polymorphism to determine if certain genotypes are more vulnerable to the effects of transient serotonin fluctuations.

Methodology

The study employed a rigorous within-subject, randomized, double-blind, placebo-controlled pharmacological fMRI design. The sample consisted of 51 healthy male participants, stratified into two groups based on their TPH2 genotype: GG carriers (hypothesized to be more vulnerable) and TT carriers.

Each participant underwent two experimental sessions. In the ATD session, they consumed an amino acid drink lacking tryptophan to induce a temporary drop in serotonin. In the placebo (PLC) session, the drink included tryptophan. Five hours post-ingestion, participants performed an emotional face-matching task during fMRI scanning. This task required them to match facial expressions (angry, fearful, happy, or neutral), allowing researchers to measure neural reactivity to both threat-related and positive stimuli. The primary regions of interest were the ventromedial prefrontal cortex (vmPFC) and the amygdala, components of the brain's "top-down" emotional regulation circuit.

Results

The Necessity of Genetic Stratification

A key finding was that ATD had no significant main effect on subjective mood or neural reactivity when the entire sample was analyzed as a single group. This highlights why previous serotonin research may have been inconsistent: the effects of serotonin depletion are masked unless individual genetic differences are considered.

Subjective Anxiety and the GG Genotype

When accounting for genotype, a clear pattern emerged. GG carriers reported a significant increase in subjective anxious arousal following serotonin depletion compared to the placebo condition ($p = 0.013$). In contrast, TT carriers showed no such increase in anxiety levels under ATD.

Neural Reactivity in the vmPFC

The behavioral findings were mirrored by neural activity in the vmPFC, a region critical for the cognitive regulation of emotion. Under the ATD condition, GG carriers exhibited significantly reduced vmPFC reactivity to threat-related stimuli, specifically fearful ($p = 0.034$) and angry ($p = 0.043$) faces. This suggests that for GG carriers, low serotonin levels impair the prefrontal cortex's ability to process or regulate threat signals.

Furthermore, the researchers found a significant positive correlation ($r = 0.502$) within the GG group: individuals who showed the greatest decrease in vmPFC reactivity also reported the highest levels of subjective anxiety. Interestingly, the study found no robust interaction effects in the amygdala, suggesting that the vulnerability associated with the TPH2 gene is primarily related to prefrontal regulation rather than "bottom-up" emotional reactivity.

Discussion

These results provide evidence that the TPH2 rs4570625 polymorphism determines how an individual's brain and mood respond to a transient decrease in serotonin. The findings suggest that the GG genotype represents a vulnerability factor, where low serotonin leads to a failure in vmPFC-mediated emotion regulation, manifesting as increased anxiety.

While the study is limited by its male-only sample and the relatively small size typical of pharmacological fMRI trials, it has significant implications for personalized medicine. Understanding these genetic predispositions could eventually help clinicians predict which patients might be most sensitive to serotonin-targeting treatments, such as SSRIs, or identify individuals at higher risk for developing anxiety disorders during periods of physiological stress. Future research should aim to replicate these findings in female populations and explore the clinical utility of TPH2 genotyping in psychiatric populations.

Summary updated

Abstract

Abstract Serotonin (5-HT) has long been implicated in adaptive emotion regulation as well as the development and treatment of emotional dysregulations in mental disorders. Accumulating evidence suggests that a genetic vulnerability may render some individuals at a greater risk for the detrimental effects of transient variations in 5-HT signaling. The present study aimed to investigate whether individual variations in the Tryptophan hydroxylase 2 (TPH2) genetics influence susceptibility for behavioral and neural threat reactivity dysregulations during transiently decreased 5-HT signaling. To this end, interactive effects between TPH2 (rs4570625) genotype and acute tryptophan depletion (ATD) on reactivity towards angry, neutral and happy faces were examined in a within-subject placebo-controlled pharmacological fMRI trial (n = 51). An a priori genotype stratification approach of extreme groups (GG vs. TT) allowed balanced sampling. While no main effects of ATD on neural reactivity to threat-related stimuli and mood state were observed in the entire sample, accounting for TPH2 genotype revealed an ATD-induced increase in subjective anxious arousal in the GG but not the TT carriers. The effects were mirrored on the neural level, such that ATD specifically reduced ventromedial prefrontal cortex (vmPFC) reactivity towards threat-related stimuli in the GG carriers. Furthermore, the ATD-induced increase in subjective anxiety positively associated with the extent of ATD-induced changes in vmPFC activity in response to threat-related stimuli in GG carriers. Together the present findings suggest for the first time that individual variations in TPH2 genetics render individuals susceptible to the anxiogenic and neural effects of a transient decrease in 5-HT signaling.
BibTeX
@misc{liu2023central,
  author = {Congcong Liu and Keshuang Li and Meina Fu and Yingying Zhang and Cornelia Sindermann and Christian Montag and Xiaoxiao Zheng and Hongxing Zhang and Yao Shuxia and Zheng Wang and Bo Zhou and Keith M. Kendrick and Benjamin Becker},
  title = {{A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity}},
  year = {2023},
  doi = {10.1101/2023.03.18.23287402},
  howpublished = {medRxiv},
}
Figure